Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew N Phillips

Showing results (161-170 of 287) with videos related to

Pageof 29
Sort By:
The Journal of Infectious Diseases|June 3, 2006
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loadsAlessandro Cozzi-Lepri, Andrea De Luca, Andrew N Phillips, et al.
Plos Medicine|June 18, 2021
Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
AIDS Care|March 3, 2020
Attitudes to disclosure of HIV-serostatus to new sexual partners and sexual behaviours among HIV-diagnosed gay, bisexual and other men who have sex with men in the UKMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
Sexually Transmitted Infections|July 7, 2017
Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmissionMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
The International Journal on Drug Policy|February 13, 2017
Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinicsJaney Sewell, Ada Miltz, Fiona C Lampe, et al.
Trials|March 13, 2022
Differentiated prevention and care to reduce the risk of HIV acquisition and transmission among female sex workers in Zimbabwe: study protocol for the 'AMETHIST' cluster randomised trialFrances M Cowan, Fortunate Machingura, Sungai T Chabata, et al.
Nature Communications|December 13, 2025
Impact and cost-effectiveness of the community-led AMETHIST intervention among female sex workers in ZimbabweLoveleen Bansi-Matharu, Collin Mangenah, Paul Revill, et al.
BMJ Global Health|December 4, 2024
Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2Brooke E Nichols, Alexandra de Nooy, Naseem Cassim, et al.
The Lancet. HIV|October 2, 2015
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisAndrew N Phillips, Valentina Cambiano, Alec Miners, et al.
Pageof 29

Showing results (161-170 of 287) with videos related to

Sort By:
Pageof 29
The Journal of Infectious Diseases|June 3, 2006
A comparison between abacavir and efavirenz as the third drug used in combination with a background therapy regimen of 2 nucleoside reverse-transcriptase inhibitors in patients with initially suppressed viral loadsAlessandro Cozzi-Lepri, Andrea De Luca, Andrew N Phillips, et al.
Plos Medicine|June 18, 2021
Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort studyNadia Hanum, Valentina Cambiano, Janey Sewell, et al.
AIDS Care|March 3, 2020
Attitudes to disclosure of HIV-serostatus to new sexual partners and sexual behaviours among HIV-diagnosed gay, bisexual and other men who have sex with men in the UKMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
Sexually Transmitted Infections|July 7, 2017
Condomless sex in HIV-diagnosed men who have sex with men in the UK: prevalence, correlates, and implications for HIV transmissionMarina Daskalopoulou, Alison J Rodger, Andrew N Phillips, et al.
AIDS (London, England)|September 28, 2002
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapyGilbert Greub, Alessandro Cozzi-Lepri, Bruno Ledergerber, et al.
The International Journal on Drug Policy|February 13, 2017
Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinicsJaney Sewell, Ada Miltz, Fiona C Lampe, et al.
Trials|March 13, 2022
Differentiated prevention and care to reduce the risk of HIV acquisition and transmission among female sex workers in Zimbabwe: study protocol for the 'AMETHIST' cluster randomised trialFrances M Cowan, Fortunate Machingura, Sungai T Chabata, et al.
Nature Communications|December 13, 2025
Impact and cost-effectiveness of the community-led AMETHIST intervention among female sex workers in ZimbabweLoveleen Bansi-Matharu, Collin Mangenah, Paul Revill, et al.
BMJ Global Health|December 4, 2024
Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2Brooke E Nichols, Alexandra de Nooy, Naseem Cassim, et al.
The Lancet. HIV|October 2, 2015
Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysisAndrew N Phillips, Valentina Cambiano, Alec Miners, et al.
Pageof 29